OASMIA PHARMACEUTICAL
Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.
OASMIA PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1990-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.oasmia.com
Total Employee:
51+
Status:
Active
Contact:
46 18 50 54 40
Email Addresses:
[email protected]
Total Funding:
36.95 M USD
Technology used in webpage:
SPF SSL By Default Apple Mobile Web Clips Icon Wordpress Plugins Amazon Microsoft Azure DNS Network Solutions DNS Browse Happy Zendesk Twitter CDN
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Yorkville Advisors
Yorkville Advisors investment in Post-IPO Equity - Oasmia Pharmaceutical
Official Site Inspections
http://www.oasmia.com
- Host name: 46.253.206.129
- IP address: 46.253.206.129
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Oasmia Pharmaceutical"
Oasmia announces completion of name change to …
Solna, Sweden, 28 March 2022 – Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, announces that as of today, 28 March, its new name, Vivesto AB, has been registered with the Swedish …See details»
Oasmia Pharmaceutical - Crunchbase Company Profile & Funding
Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well …See details»
Oasmia announces intention to change its name to Vivesto
Solna, Sweden, January 19, 2022 – Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, today announces plans to change its name to Vivesto AB.The …See details»
Oasmia announces intention to change its name to Vivesto
Press Release 19 January 2022 07:35:00 CET Oasmia Pharmaceutical Vallongatan 1 SE-752 28 Uppsala About Oasmia Pharmaceutical AB Oasmia is a specialty pharmaceutical company …See details»
Oasmia announces completion of name change to Vivesto AB
Mar 28, 2022 The new name, Vivesto AB, which was approved at the Extraordinary General Meeting on 21 February 2022, reflects the company’s commitment to improve survival and …See details»
Oasmia Pharmaceuticals - Products, Competitors, Financials, …
Oct 23, 2015 Oasmia Pharmaceuticals, also known as Vivesto, is a pharmaceutical company focused on the development of new treatment options for cancer. Use the CB Insights …See details»
Oasmia Pharmaceutical AB - Uppsala, Sweden - bionity.com
At Oasmia Pharmaceutical AB we are developers of a new generation of drugs within the fields of human and veterinary oncology. We aim to develop and manufacture novel anti-cancer …See details»
Oasmia Pharmaceutical — Onwards and upwards - Edison Group
Mar 12, 2021 Oasmia is at a major inflection point as it focuses on its transformation into an R&D-driven, specialty pharma company, with commercially available assets.See details»
Oasmia Pharmaceutical — A definitive year ahead - Edison Group
Dec 6, 2021 We believe Oasmia is entering a definitive phase of its transformation in the months ahead. Apealea is due to be launched in Europe (early 2022), enabling an inflow of …See details»
Oasmia Pharmaceutical — Clarity on pathway to US approval
Dec 17, 2020 Oasmia’s H1 FY21 results highlight recent developments made to realign the business. In December, global partner Elevar Therapeutics announced it had concluded …See details»
Oasmia publishes Annual Report for 2020 – Vivesto
Apr 29, 2021 For More Information: Francois Martelet, Chief Executive Officer Phone: +46 18-50 54 40 E-mail: [email protected] About Oasmia Pharmaceutical AB Oasmia is a specialty …See details»
Lonza signs manufacturing agreement with Oasmia for ovarian …
Mar 21, 2022 Lonza Group said on Monday it signed a manufacturing agreement with Sweden's Oasmia Pharmaceutical for ovarian cancer drug candidate Cantrixil that was licensed by …See details»
Oasmia Pharmaceutical AB: Swedish Company Targeting Ovarian …
Jun 17, 2019 Oasmia Pharmaceutical AB (OASM) is a Swedish company which is very diversified both geographically and in target patients. The company develops oncology drugs …See details»
Osmia - Crunchbase Company Profile & Funding
Osmia products are made with natural ingredients, always consciously sourced, and organic whenever possible. Products are made without the following ingredients: parabens, …See details»
Oasmia Pharmaceutical AB (publ) - Vivesto
Organization Swiss Group for Clinical Cancer Research (SAKK) which has been conducting clinical trials in oncology since 1965. Prostate cancer is a significant and increasingly prevalent …See details»
Oasmia Pharmaceutical — Focused on pillars of growth
Oct 7, 2021 Oasmia Pharmaceutical has made steady progress in its ongoing transition into an R&D-driven, speciality pharma company with commercially available assets.See details»
Osmia: Natural Skincare for Healthier, Happier Skin
Osmia is a doctor-formulated line of natural skincare products for all skin types including challenging skin conditions like dermatitis, acne, and eczema. Our team can help you choose …See details»
Mason bee - Wikipedia
Mason bee is a name now commonly used for species of bees in the genus Osmia, of the family Megachilidae.Mason bees are named for their habit of using mud or other "masonry" products …See details»
Oasmia strengthens internal capabilities with the ... - Vivesto
Solna, Sweden, August 26, 2021 – Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, today announces the appointments of Kia Bengtsson as Head of …See details»
Osmia | The Detox Market - Canada
Osmia Founded by emergency physician turned skincare pioneer Sarah Villafranco, M.D., Osmia Organics merges skincare with aromatherapy as a reminder to notice and enjoy the beauty in …See details»